Alerce Investment Management, L.P. 13F annual report

Alerce Investment Management, L.P. is an investment fund managing more than $51 billion ran by Muneer Satter. There are currently 5 companies in Mr. Satter’s portfolio. The largest investments include Annexon Inc and Akebia Therapeutics, together worth $42.2 billion.

$51 billion Assets Under Management (AUM)

As of 7th August 2024, Alerce Investment Management, L.P.’s top holding is 7,406,024 shares of Annexon Inc currently worth over $36.3 billion and making up 71.1% of the portfolio value. In addition, the fund holds 5,747,906 shares of Akebia Therapeutics worth $5.86 billion, whose value fell 12.4% in the past six months. The third-largest holding is American Well Corp worth $3.4 billion and the next is Verona Pharma Plc worth $3.08 billion, with 213,000 shares owned.

Currently, Alerce Investment Management, L.P.'s portfolio is worth at least $51 billion. The total portfolio value may be much higher due to cash assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.

Careers at Alerce Investment Management, L.P.

The Alerce Investment Management, L.P. office and employees reside in Chicago, Illinois. According to the last 13-F report filed with the SEC, Muneer Satter serves as the Trustee of Managing Mbr of GP of Alerce Investment Managemen at Alerce Investment Management, L.P..

Recent trades

In the most recent 13F filing, Alerce Investment Management, L.P. revealed that it had opened a new position in Verona Pharma Plc and bought 213,000 shares worth $3.08 billion.

On the other hand, there are companies that Alerce Investment Management, L.P. is getting rid of from its portfolio. Alerce Investment Management, L.P. closed its position in Aileron Therapeutics Inc on 14th August 2024. It sold the previously owned 830,466 shares for $5.51 billion. Muneer Satter also disclosed a decreased stake in Akebia Therapeutics by 0.6%. This leaves the value of the investment at $5.86 billion and 5,747,906 shares.

One of the smallest hedge funds

The two most similar investment funds to Alerce Investment Management, L.P. are Velt Partners Investimentos Ltda and Sonen Capital. They manage $51.1 billion and $50.9 billion respectively.

Muneer Satter investment strategy

Alerce Investment Management, L.P.’s portfolio is diversified across 2 sectors. Currently, their heaviest sector is Health Care — making up 24.2% of the total portfolio value. The fund focuses on investments in the United States as 40.0% of the portfolio companies are based in the United States.

The majority of the companies in the fund’s portfolio are small-cap stocks. Stocks with a size of more than $100 million in market cap make up 20% of the total holdings value. On the other hand, large-cap stocks make up only approximately 0.1% of the portfolio. The average market cap of the portfolio companies is close to $660 million.

The complete list of Alerce Investment Management, L.P. trades based on 13F SEC filings

These positions were updated on August 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.

Security	Shares Owned	Value	Allocation
Annexon Inc	No change 7,406,024	$36,289,518,000	71.13%
Akebia Therapeutics Inc.	56.47% 5,747,906	$5,862,864,000	11.49%
Aileron Therapeutics Inc	Closed 830,466	$5,505,990,000
American Well Corp	No change 10,475,717	$3,402,513,000	6.67%
Verona Pharma Plc	Opened 213,000	$3,079,980,000	6.04%
Aadi Bioscience Inc	No change 1,630,830	$2,381,012,000	4.67%
No transactions found
Showing first 500 out of 6 holdings